1. Home
  2. DFH vs VCEL Comparison

DFH vs VCEL Comparison

Compare DFH & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dream Finders Homes Inc.

DFH

Dream Finders Homes Inc.

N/A

Current Price

$15.57

Market Cap

1.7B

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

N/A

Current Price

$32.92

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DFH
VCEL
Founded
2008
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
DFH
VCEL
Price
$15.57
$32.92
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$26.00
$58.50
AVG Volume (30 Days)
474.9K
412.7K
Earning Date
05-28-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
2.14
0.32
Revenue
$4,322,848,000.00
$276,259,000.00
Revenue This Year
$1.48
$19.09
Revenue Next Year
$6.88
$17.96
P/E Ratio
$7.38
$104.28
Revenue Growth
N/A
16.45
52 Week Low
$14.88
$29.24
52 Week High
$31.10
$48.75

Technical Indicators

Market Signals
Indicator
DFH
VCEL
Relative Strength Index (RSI) 23.69 34.92
Support Level N/A $31.34
Resistance Level $20.26 $38.48
Average True Range (ATR) 0.84 1.42
MACD -0.41 -0.36
Stochastic Oscillator 9.67 4.86

Price Performance

Historical Comparison
DFH
VCEL

About DFH Dream Finders Homes Inc.

Dream Finders Homes Inc designs, builds and sells homes in markets throughout the United States. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the maximum of its revenue from the Midwest segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: